Competitive Edge Labs MPC-185 - Muscle Peptide Compound 185

Research-Grade Anabolic Peptide for Muscle Growth, Strength, and Recovery

Featuring DL-185 Dileucine Peptide – Clinically Studied for Enhanced Muscle Protein Synthesis

Competitive Edge Labs MPC-185 is a next-generation muscle-building and performance-enhancing supplement powered by DL-185, a patented and clinically studied dileucine peptide. Designed for athletes, bodybuilders, and fitness enthusiasts, MPC-185 delivers superior anabolic and anti-catabolic benefits—backed by published human clinical research.

This groundbreaking formula has been shown to activate muscle protein synthesis (MPS) 159% above baseline and 60% more than traditional leucine, translating into substantial gains in lower body strength, total body strength, and muscular endurance.

MPC-185 Highlights

159% Greater Activation of Muscle Protein Synthesis

Boosts Lower Body Strength & Reps to Failure

Increases Total Body Strength and Power Output

Enhances Lean Muscle Growth

Accelerates Muscle Recovery

Anabolic and Anti-Catabolic Effects

Supported by Human Clinical Research

Who Is MPC-185 For?

Weight Trainers & Bodybuilders

Strength & Endurance Athletes

Recovery-Focused Trainers

Individuals Aiming to Preserve Muscle Mass

Active Lifestyle & Longevity Enthusiasts

Anyone Looking to Perform, Recover, and Look Better

What Is MPC-185?

MPC-185 is a clinically supported, research-grade anabolic peptide supplement featuring DL-185 a patented peptide comprised of two bonded leucine molecules (dileucine). This innovative structure allows DL-185 to enter the bloodstream intact and outperform standard leucine in stimulating MPS.

While leucine has long been regarded as the “anabolic trigger,” DL-185 redefines what’s possible by activating muscle protein synthesis to a significantly greater degree unlocking new levels of muscle growth, strength, and endurance.

Proven Clinical Results
Study #1 – Journal of Applied Physiology (2021):
A double-blind, randomized, crossover study demonstrated that DL-185 increased muscle protein synthesis by 159% over baseline and 60% more than leucine in healthy young males.

Study #2 – PLOS One (2024):
A 10-week randomized, double-blind, placebo-controlled human trial examined the impact of DL-185 on strength and endurance in resistance-trained males.

MPC-185 Findings:

Total Max Strength:

DL-185 users increased total strength by 154 lbs vs. 63 lbs in the placebo group (a 144% improvement).

Lower Body Strength:

DL-185 users gained 133 lbs vs. 46 lbs with placebo—a 189% greater improvement.

Lower Body Reps to Failure:

Participants taking DL-185 added 16 extra reps, compared to only 5 in the leucine group—220% greater improvement.

These results confirm DL-185’s superiority in both muscle protein synthesis and real-world performance metrics.

Understanding the Science:

Muscle Protein Synthesis (MPS) Explained

Muscle protein synthesis is the body’s process of repairing and building muscle fibers after exercise. When MPS exceeds muscle protein breakdown (MPB), muscle growth occurs. MPC-185 promotes this positive protein balance by triggering MPS more effectively than leucine alone.

Leucine vs. DL-185: Why Dileucine Is Superior

Leucine: The amino acid known for initiating MPS by activating the mTOR pathway. However, it has a threshold—typically 2-3 grams—beyond which no further benefit is observed.

DL-185: A unique peptide that not only meets the leucine threshold but exceeds its effects by 60%, delivering stronger anabolic signaling and better muscle-building potential.

This is why MPC-185 is not just a leucine supplement—it’s a new category of muscle enhancement.

What Sets DL-185 Apart?

Patented Dipeptide Structure: Enhances bioavailability and delivers superior signaling to activate MPS.

Clinically Dosed: Each serving of MPC-185 provides the full 2,000 mg dose used in clinical trials.

Real-World Performance: Demonstrated increases in strength and endurance—far beyond traditional amino acid supplements.